Staar Surgical Co STAA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
STAAR Surgical Announces Participation in Upcoming Investor Conferences
-
STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
-
STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
-
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
-
Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win
-
Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical
-
Staar Surgical Shares Surge as Alcon Boosts its Buyout Price
-
Alcon Upgrades Offer Price for Staar Surgical
Trading Information
- Previous Close Price
- $28.37
- Day Range
- $28.52–29.20
- 52-Week Range
- $15.59–35.87
- Bid/Ask
- $28.89 / $28.92
- Shares Outstanding
- 49.79M
- Market Cap
- $1.44B
- Volume/Avg
- 471,845 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 66.20
- Price/Sales
- 4.88
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.61%
Company Profile
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 957
- Website
- https://www.staar.com
Valuation
|
Metric
|
STAA
|
|---|---|
Price/Earnings (Normalized) | 66.20 |
Price/Book Value | 3.99 |
Price/Sales | 4.88 |
Price/Cash Flow | 37.08 |
Price/Earnings
STAA
Financial Strength
|
Metric
|
STAA
|
|---|---|
Quick Ratio | 4.09 |
Current Ratio | 5.12 |
Interest Coverage | — |
Quick Ratio
STAA
Profitability
|
Metric
|
STAA
|
|---|---|
Return on Assets (Normalized) | 9.13% |
Return on Equity (Normalized) | 11.84% |
Return on Invested Capital (Normalized) | 9.82% |
Return on Assets
STAA
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Tdfgvcpsb | Thwm | $146B | |||
| Becton Dickinson & Co
BDX
| Qjhyd | Hjzymv | $40B | |||
| Alcon Inc
ALC
| Bqjfwlbp | Vycbr | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| Bwmcddfv | Xxdmv | $31B | |||
| ResMed Inc
RMD
| Cvzxrsws | Ypwkjq | $28B | |||
| West Pharmaceutical Services Inc
WST
| Xvjqwzddsj | Qkl | $23B | |||
| Solventum Corp
SOLV
| Mtrdfcsr | Rxpp | $14B | |||
| The Cooper Companies Inc
COO
| Xzgpvqzcc | Zzqmtr | $13B | |||
| Align Technology Inc
ALGN
| Vwryzhjr | Jfjdr | $13B | |||
| Baxter International Inc
BAX
| Jlht | Hlvqb | $11B |
United States